BioVie completes patient visits for Parkinson's drug trial

May 18, 2026 8:01 AM

BioVie Inc. (NASDAQ: BIVI) completed the last patient evaluation visit for its SUNRISE-PD Phase 2 trial testing bezisterim in early-stage ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found